These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9347389)

  • 1. Early onset of therapeutic action in depression and greater efficacy of antidepressant treatments: are they related?
    Blier P; Bergeron R
    Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S21-8. PubMed ID: 9347389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing antidepressant treatment: efficacy and tolerability.
    Deakin B; Dursun S
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-24. PubMed ID: 12369607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.
    Blier P; de Montigny C
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):91S-98S. PubMed ID: 10432494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How to treat and manage unsatisfactory response?].
    El-Hage W; Fakra E
    Encephale; 2016 Feb; 42(1 Suppl 1):1S39-47. PubMed ID: 26879256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating antidepressant nonresponders with augmentation strategies: an overview.
    Thase ME; Howland RH; Friedman ES
    J Clin Psychiatry; 1998; 59 Suppl 5():5-12; discussion 13-5. PubMed ID: 9635543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the mechanism of Ketamine's rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities.
    Strasburger SE; Bhimani PM; Kaabe JH; Krysiak JT; Nanchanatt DL; Nguyen TN; Pough KA; Prince TA; Ramsey NS; Savsani KH; Scandlen L; Cavaretta MJ; Raffa RB
    J Clin Pharm Ther; 2017 Apr; 42(2):147-154. PubMed ID: 28111761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice.
    Prescrire Int; 2011 May; 20(116):128-33. PubMed ID: 21648180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of the depressive component of bipolar disorder.
    Kalin NH
    Depress Anxiety; 1996-1997; 4(4):190-8. PubMed ID: 9166651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current advances and trends in the treatment of depression.
    Blier P; de Montigny C
    Trends Pharmacol Sci; 1994 Jul; 15(7):220-6. PubMed ID: 7940983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of putative early-onset antidepressant strategies.
    Blier P
    Eur Neuropsychopharmacol; 2003 Mar; 13(2):57-66. PubMed ID: 12650947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation strategies for treatment-resistant depression.
    Ros S; Agüera L; de la Gándara J; Rojo JE; de Pedro JM
    Acta Psychiatr Scand Suppl; 2005; (428):14-24, 36. PubMed ID: 16307616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of depression and mixed states in bipolar disorder.
    Montgomery SA; Schatzberg AF; Guelfi JD; Kasper S; Nemeroff C; Swann A; Zajecka J
    J Affect Disord; 2000 Sep; 59 Suppl 1():S39-S56. PubMed ID: 11121826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.
    Blier P; de Montigny C; Chaput Y
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):24S-35S. PubMed ID: 3323264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment strategies in achieving remission in major depressive disorder.
    Kelsey JE
    Acta Psychiatr Scand Suppl; 2002; (415):18-23. PubMed ID: 12492769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How fast are antidepressants?
    Gelenberg AJ; Chesen CL
    J Clin Psychiatry; 2000 Oct; 61(10):712-21. PubMed ID: 11078031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ideal trial to test differential onset of antidepressant effect.
    Leon AC; Blier P; Culpepper L; Gorman JM; Hirschfeld RM; Nierenberg AA; Roose SP; Rosenbaum JF; Stahl SM; Trivedi MH
    J Clin Psychiatry; 2001; 62 Suppl 4():34-6; discussion 37-40. PubMed ID: 11229787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in pharmacological and non-pharmacological treatment options of major depression.
    Baghai TC; Möller HJ; Rupprecht R
    Curr Pharm Des; 2006; 12(4):503-15. PubMed ID: 16472142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.